IL37 and colorectal carcinoma: However, in an experimental model of colitis-induced colorectal cancer (CRC), IL-37 transgenic mice were more prone to the development of tumors and were also characterized by significantly enlarged tumor burdens and impaired function of CD8+ T cells, supporting its tumor promoting effect in this case [21].